BioInfra Co., Ltd. (KOSDAQ:199730)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,950.00
+235.00 (6.33%)
At close: Mar 12, 2026
Market Cap19.46B -27.0%
Revenue (ttm)21.92B -16.2%
Net Income-5.63B
EPS-1,157.24
Shares Out4.86M
PE Ration/a
Forward PEn/a
Dividend400.00 (11.54%)
Ex-Dividend DateDec 29, 2025
Volume17,658
Average Volume18,406
Open3,845.00
Previous Close3,715.00
Day's Range3,715.00 - 4,000.00
52-Week Range3,200.00 - 7,620.00
Beta0.55
RSI47.28
Earnings Daten/a

About BioInfra

BioInfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. The company provides clinical, which undertakes clinical trials for new drug development approval (Phase I-III) and late clinical trials; immunoassay, which performs pharmacokinetic, toxicokinetic, and biomarker analysis of polymer biopharmaceuticals; and testing and inspection, which provides finished drug product quality inspection, comparative dissolution testing, and long-term stability testing. It also specializes in bioequivalence testing of gener... [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 199730
Full Company Profile

Financial Performance

Financial Statements